Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
GeneDx Holdings Corp - SIC # 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
WGS
Nasdaq
2835
https://sema4.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for GeneDx Holdings Corp
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
- Apr 23rd, 2024 12:30 pm
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
- Apr 4th, 2024 8:05 pm
Here's Why GENEDX HOLDINGS (WGS) Could be Great Choice for a Bottom Fisher
- Mar 21st, 2024 1:55 pm
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
- Mar 14th, 2024 12:30 pm
GeneDx to Participate in 44th Annual Cowen Health Care Conference
- Feb 26th, 2024 9:05 pm
20 Most Valuable Digital Health Companies In The US
- Feb 23rd, 2024 10:15 am
GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2023 Earnings Call Transcript
- Feb 21st, 2024 1:33 pm
Q4 2023 GeneDx Holdings Corp Earnings Call
- Feb 21st, 2024 11:37 am
GeneDx Holdings Corp (WGS) Reports Strong Revenue Growth and Margin Expansion in Q4 2023
- Feb 20th, 2024 10:02 pm
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
- Feb 20th, 2024 9:26 pm
GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024
- Feb 1st, 2024 9:30 pm
Institutional investors own a significant stake of 44% in GeneDx Holdings Corp. (NASDAQ:WGS)
- Jan 31st, 2024 11:44 am
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jan 24th, 2024 9:30 pm
GeneDx Announces Preliminary 2023 Financial Results
- Jan 8th, 2024 1:55 pm
GeneDx Holdings Corp. (NASDAQ:WGS) Surges 52% Yet Its Low P/S Is No Reason For Excitement
- Dec 18th, 2023 12:33 pm
Pleasing Signs As A Number Of Insiders Buy GeneDx Holdings Stock
- Dec 13th, 2023 10:52 am
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
- Dec 1st, 2023 1:30 pm
GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference
- Nov 28th, 2023 9:05 pm
Bears are Losing Control Over GeneDx Holdings Corp. (WGS), Here's Why It's a 'Buy' Now
- Nov 10th, 2023 2:55 pm
GeneDx Holdings Corp. (NASDAQ:WGS) Q3 2023 Earnings Call Transcript
- Nov 5th, 2023 5:10 pm
Scroll